Due: August 24, 2026 This funding mechanism supports high-risk/high-reward research that has the potential to make a major impact in lupus research and/or lupus disease. The emphasis is on impact. Research must address at least Read More
Due: August 13, 2026 The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the Read More
Due: August 13, 2026 The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Exploration – Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the Multiple Read More
Due: July 9, 2026 The purpose of the notice of funding opportunity (NOFO) is to solicit applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program. This new initiative will establish highly collaborative, multi-disciplinary, research teams Read More
Due: July 15, 2026 The objective of this RFI is to solicit feedback from industry, academia, and other stakeholders to assist BARDA in identifying and understanding the development maturity of Day-One influenza vaccine candidates and Read More
Due: November 18, 2026 The TechConnect Critical Technology Spotlights are an open innovation program focused on accelerating breakthrough technologies in alignment with evolving strategic priorities for national security, sustainability, and economic resilience. In 2027, the Read More
Due: June 17, 2026 The purpose of this Request for Information (RFI) is to conduct market research to identify organizations with capabilities in artificial intelligence (AI) for application in the discovery and advancement of broad-spectrum, Read More
Due: May 20, 2026 CPE CBRND is conducting essential market research for a new initiative dedicated to identifying and advancing mature, portable, and integrated mNGS systems for clinical diagnostics. The program is focused on overcoming Read More
Due: May 20, 2026 CPE CBRND is conducting essential market research for the Advanced Differential Diagnostics (ADD) program, an existing Program of Record that is developing new diagnostic capabilities in a phased approach. This program Read More
Due: June 26, 2026 Breakthrough biology exists. What’s missing is cost-competitive production, industrial integration, and real-world deployment. This challenge calls on innovators to close that gap. The Industrial Biotech Innovation Prize Challenge supports technologies that Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.